Project Number ADDF-42 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2021 View Full Project Details for Plasma neuroinflammatory biomarkers for the diagnossi of dementia subtypes Research Categorization Primary Disease / Condition Multiple Dementias CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 1. Fluid Biomarkers b. Blood-based Biomarkers Researcher and Organization Principal Investigator Pase, Matthew Principal Investigator First Name Matthew Principal Investigator Last Name Pase Awardee Organization MONASH UNIVERSITY Contact PI Country Australia Project Detail Funding Opportunity Announcement ADDF-Neuroimaging and CSF Biomarkers Program FY Overall Cost $671,160 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States Program Official ADDF Grants Management
